{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:54:20Z","timestamp":1790420060519,"version":"4.1.0"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,12,15]],"date-time":"2008-12-15T00:00:00Z","timestamp":1229299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Two patients were suspected of having immune hemolytic anemia (IHA) due to oxaliplatin. A related drug, cisplatin, is known to cause nonimmunologic protein adsorption (NIPA). Studies were performed to determine the presence of oxaliplatin\u2010dependent antibodies in addition to oxaliplatin\u2010induced NIPA.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> Sera and eluates from the two patients were tested against red blood cells (RBCs) treated with oxaliplatin, cisplatin, and carboplatin (another platinum drug). Sera were also tested against untreated RBCs in the presence of the same drugs. Testing with pooled normal sera and anti\u2010human albumin was used to demonstrate the presence of NIPA. Oxaliplatin\u2010treated RBCs sensitized with the patients' sera and pooled normal sera were tested by a monocyte monolayer assay (MMA) to determine potential clinical significance.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Both patients had high\u2010titer antibodies to oxaliplatin in their sera that reacted with oxaliplatin\u2010treated RBCs and with untreated RBCs in the presence of oxaliplatin. RBCs treated with oxaliplatin, cisplatin, and carboplatin all demonstrated NIPA (pooled normal sera and anti\u2010human albumin were reactive to low titers). NIPA was also detected in tests with untreated RBCs in the presence of oxaliplatin and cisplatin. Lower\u2010titer reactivity of both patients' sera with cisplatin may have been due to NIPA and\/or cross\u2010reactivity of anti\u2010oxaliplatin with cisplatin. MMAs were weakly positive due to NIPA and more strongly positive due to oxaliplatin antibodies.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> Two patients with IHA were demonstrated to have oxaliplatin\u2010dependent antibodies. Oxaliplatin was also shown to cause NIPA. The drug\u2010dependent antibody and\/or the drug\u2010induced NIPA could have contributed to the patients' hemolytic anemia.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2008.02028.x","type":"journal-article","created":{"date-parts":[[2008,12,15]],"date-time":"2008-12-15T23:08:43Z","timestamp":1229382523000},"page":"711-718","source":"Crossref","is-referenced-by-count":40,"title":["Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and\/or drug\u2010induced nonimmunologic protein adsorption"],"prefix":"10.1111","volume":"49","author":[{"given":"Patricia","family":"Arndt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Garratty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edahn","family":"Isaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bolger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,20]]},"reference":[{"key":"e_1_2_7_2_2","volume-title":"Immune hemolytic anemias","author":"Petz LD","year":"2004"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198002073020607"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00262747"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1988.28588337345.x"},{"key":"e_1_2_7_6_2","first-page":"102A","article-title":"Positive direct and indirect antiglobulin tests associated with oxaliplatin can be caused by antibody and\/or nonimmunologic protein adsorption [abstract","volume":"43","author":"Arndt PA","year":"2003","journal-title":"Transfusion"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.107.3.860"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00615.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)03827-1"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008336108007"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1608"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/02841860152703553"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03111.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-003-0731-8"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000081006"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.04373.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-7563.2005.00001.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.3816\/CCC.2005.n.041"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01173.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e3280102f4b"},{"key":"e_1_2_7_21_2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/CAD.0b013e3280e9496d","article-title":"Oxaliplatin\u2010induced immune hemolytic anemia: a case report and review of the literature","volume":"18","author":"Cobo F","year":"2007","journal-title":"Anticancer Drugs"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/76.1.73"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1984.24384225022.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/89.3.410"},{"key":"e_1_2_7_25_2","volume-title":"Technical manual","author":"Brecher ME","year":"2005"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1987.27688071692.x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03427.x"},{"key":"e_1_2_7_28_2","first-page":"24S","article-title":"Is severe immune hemolytic anemia, following a single dose of cefotetan, associated with the presence of \u201cnaturally\u2010occurring\u201d anti\u2010cefotetan? [abstract","volume":"41","author":"Arndt P","year":"2001","journal-title":"Transfusion"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0958-7578.2004.00481.x"},{"key":"e_1_2_7_30_2","first-page":"119S","article-title":"Can nonspecific protein coating of RBCs lead to increased RBC destruction? Drug\u2010treated RBCs with positive antiglobulin tests due to nonspecific protein uptake give positive monocyte monolayer assays [abstract","volume":"40","author":"Arndt P","year":"2000","journal-title":"Transfusion"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2008.02028.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2008.02028.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:53:29Z","timestamp":1697262809000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2008.02028.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,20]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1537-2995.2008.02028.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2008.02028.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,20]]}}}